共 50 条
- [1] Recurrent adamantinomatous craniopharyngioma stabilized with tocilizumab and bevacizumab: illustrative case JOURNAL OF NEUROSURGERY-CASE LESSONS, 2025, 9 (02):
- [2] A Novel Immune Classification for Predicting Immunotherapy Responsiveness in Patients With Adamantinomatous Craniopharyngioma FRONTIERS IN NEUROLOGY, 2021, 12
- [6] Adamantinomatous craniopharyngioma in the molecular age and the potential of targeted therapies: a review Child's Nervous System, 2020, 36 : 1635 - 1642
- [9] Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma Acta Neuropathologica, 2012, 124 : 259 - 271
- [10] Identification of the MAPK/ERK Pathway as a Novel Therapeutic Target in Adamantinomatous Craniopharyngioma HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 58 - 59